Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Promisia Healthcare Limited ( (NZ:PHL) ) is now available.
Promisia Healthcare Limited has issued 50,000 new ordinary shares following the conversion of an equivalent number of unquoted restricted share units under its 2023 Senior Executive Restricted Share Unit Plan. The issue, priced at a volume-weighted average price of $0.4663 per share and fully paid via services rendered, represents about 0.095% of shares on issue, with 10,000 RSUs cancelled and total ordinary shares now standing at 52,804,550.
A related disclosure notice shows that Chief Financial Officer Francisco Rodriguez Ferrere increased his holding from 60,000 to 146,600 Promisia shares through two RSU conversions, including the latest 50,000-share issuance. The transactions, conducted outside closed trading periods, underscore the company’s ongoing use of equity-based incentives to align senior management interests with those of shareholders.
More about Promisia Healthcare Limited
Promisia Healthcare Limited is a New Zealand-listed healthcare company operating under the ticker PHL. It issues ordinary shares and uses senior executive restricted share unit (RSU) schemes as part of its remuneration and incentive structures for key management staff.
Average Trading Volume: 10,021
Technical Sentiment Signal: Strong Sell
Current Market Cap: N$23.46M
Learn more about PHL stock on TipRanks’ Stock Analysis page.